Pharmacovigilance Literature Monitoring is a critical component of drug safety surveillance that has traditionally been time-consuming and resource-intensive, particularly at the local level. Our AI-powered solution transforms this landscape by automating the screening of global and local medical literature sources, ensuring no potential safety signal goes undetected while dramatically reducing manual effort and operational costs.
We recognized that literature monitoring in pharmacovigilance had always been a labor-intensive activity, especially when navigating local language publications across multiple markets. We decided to change this status quo by developing the first user-friendly product capable of automatically screening both global and local sources simultaneously. Today, our solution remains unmatched in the industry. It continues to improve with new sources regularly added, new products ready to be monitored within minutes of launch, and innovative features such as AI-powered assessment that further reduce human effort. This is the largest dataset of sources for pharmacovigilance monitoring, where integrated artificial intelligence replaces manual work, enabling tens of thousands of articles to be screened efficiently.
Figure 1. Pharmacovigilance Literature Monitoring.
Our pharmacovigilance literature monitoring service supports a wide range of drug safety activities:
Our pharmacovigilance literature monitoring service is built on the world's largest and most sophisticated automated screening platform, delivering comprehensive coverage that no other provider can match. This all-in-one solution combines extensive source access with intelligent automation to transform how pharmaceutical companies approach literature safety surveillance:
AI-Powered Relevance Assessment
Advanced artificial intelligence algorithms evaluate each literature hit for relevance, significantly reducing false positives and ensuring that only clinically meaningful information requires human review. The AI continuously learns from expert feedback, becoming smarter and more accurate with every interaction to further streamline your workflow.
Automated Data Population
When a relevant individual case safety report is identified, the system automatically populates structured data fields, including E2B-compliant formats, ready for expert quality control and regulatory submission. This eliminates hours of manual data entry and virtually eliminates transcription errors that can occur with traditional manual processing.
Complete Integration
While powerful as a standalone solution, our literature monitoring service integrates seamlessly with broader pharmacovigilance activities, with outputs directly visible to your qualified persons for pharmacovigilance, local responsible persons, and affiliate teams by country. This connected approach ensures that safety intelligence flows effortlessly to everyone who needs it, when they need it.
Our streamlined process ensures efficient, accurate literature monitoring from initial search through to regulatory submission:
Data Collection: Multisource Gathering: This initial stage focuses on aggregating pharmacovigilance-related data from diverse literature sources, including peer-reviewed journals, clinical trial registries, case reports, and post-marketing surveillance databases.
Data Extraction: Following data collection, the process moves to extracting actionable safety information from both structured and unstructured formats. Structured data (e.g., standardized clinical trial results, database entries) is systematically parsed for predefined fields like adverse event terms, patient demographics, and drug dosages.
Signal Detection: In this stage, potential safety signals are identified through a dual approach of algorithmic analysis and manual review. Automated algorithms sift through extracted data to detect statistical associations between drugs and adverse events, flagging unusual patterns or clusters.
Risk Assessment: Detected signals undergo rigorous benefit-risk evaluation to determine their clinical significance. This involves analyzing the severity, frequency, and preventability of adverse events, alongside the therapeutic benefits of the drug in its intended patient population.
Continuous Improvement
Our source database grows continuously with new publications added regularly, and our AI algorithms learn from every interaction to improve relevance assessment over time. Your literature monitoring actually gets better the longer you use it, adapting to new sources and evolving safety concerns automatically.
Complete Audit Trail
Every search, hit, assessment, and submission is fully documented, ensuring you are always inspection-ready with comprehensive, traceable records. When regulators come calling, you can provide complete documentation of your literature monitoring activities with just a few clicks.
Low management overhead
With the assistance of artificial intelligence, complete automation eliminates manual management tasks, allowing teams to focus on value-added scientific activities. High skilled pharmacovigilance professionals can apply their expertise to protect patients, rather than duplicating data input.
Going through tens of thousands of articles has never been easier. Our pharmacovigilance literature monitoring solution represents the first among all literature monitoring solutions in size, quality, and efficiency. With the largest dataset of sources for pharmacovigilance monitoring, integrated artificial intelligence that replaces manual human work, and complete automation that virtually eliminates administrative overhead, we have transformed a traditionally time-consuming activity into a streamlined, cost-effective operation. Experience the difference of truly automated literature monitoring. Discover how our solution can ensure your complete legal compliance while freeing your team to focus on what matters most—protecting patient safety.
